Search results

Slaughter and May is advising Derwent London on the disposal of 2 & 4 Soho Place Slaughter and May is advising Derwent London on the disposal of 2 & 4 Soho Place Slaughter and May is advising Baker McKenzie on its new London office Slaughter and May is advising Baker McKenzie on its new London office Slaughter and May is advising Aston Martin Lagonda on its initial public offering laughter and May is advising Aston Martin Lagonda Global Holdings plc (“Aston Martin Lagonda” or the “Company”), the iconic producer of hand-crafted luxury sports cars, on the proposed initial public offering of ordinary shares (the “Offer”). Slaughter and May is advising Centrica plc on its agreement to sell its North American energy supply, services and trading business, Direct Energy, to NRG Energy Slaughter and May is advising Centrica plc on its agreement to sell its North American energy supply, services and trading business, Direct Energy, to NRG Energy Slaughter and May advised Credit Suisse AG as secured lender in relation to the $2.2 billion restructuring of Danaos Corporation Slaughter and May advised Credit Suisse AG as secured lender in relation to the $2.2 billion restructuring of Danaos Corporation Slaughter and May advised OVO Energy on its strategic partnership with European energy supplier, Eni gas e luce Slaughter and May advised OVO Energy on its strategic partnership with European energy supplier, Eni gas e luce Slaughter and May is advising International Consolidated Airlines Group, S.A. on its proposed rights issue Slaughter and May is advising International Consolidated Airlines Group, S.A. on its proposed rights issue Slaughter and May advised CK Asset Holdings on the disposal of its interests in Chengdu Le Parc Slaughter and May, Hong Kong, advised CK Asset Holdings on the disposal of its interests in Chengdu Le Parc Slaughter and May is advising CICC on the HK$1,014.8 million (approximately US$130 million) placing by China Grand Pharmaceutical and Healthcare Holdings Slaughter and May advised Alibaba Health Information Technology Limited on its HK$10 billion primary placing